Tekmira Conference Call and Webcast Advisory: Corporate Update and Third Quarter 2012 Results

Tekmira Conference Call and Webcast Advisory: Corporate Update and Third
Quarter 2012 Results

VANCOUVER, British Columbia, Nov. 12, 2012 (GLOBE NEWSWIRE) -- Tekmira
Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of
RNA interference (RNAi) therapeutics, announced that it will hold a conference
call and webcast on Tuesday, November 13, 2012 at 4:30 am Pacific Time (7:30
am Eastern Time) to provide a corporate update and report financial and
operating results for the third quarter ended September 30, 2012.



Conference Call and Webcast Information

A live webcast of  the call can  be accessed through  the Investor section  of 
Tekmira's website at  www.tekmirapharm.com. Or, alternatively,  to access  the 
conference call,  please dial  914-495-8556  or 1-866-393-1607  and  reference 
conference ID 70796137.



An archived webcast will be available on the Tekmira website approximately two
hours after the  event. Alternatively, to  access a replay  of the  conference 
call, please dial 404-537-3406 or  1-855-859-2056 and reference conference  ID 
70796137.



About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused  on 
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to  pharmaceutical partners. Tekmira  has been working  in 
the  field  of  nucleic  acid  delivery  for  over  a  decade  and  has  broad 
intellectual property covering LNPs. Further information about Tekmira can  be 
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.



The      Tekmira      Pharmaceuticals      logo      is      available      at 
http://www.globenewswire.com/newsroom/prs/?pkgid=8319

CONTACT: Investors
         Jodi Regts
         Director, Investor Relations
         Phone: 604-419-3234
         Email: jregts@tekmirapharm.com

         Media
         David Ryan
         Longview Communications Inc.
         Phone: 416-649-8007
         Email: dryan@longviewcomms.ca

Tekmira Pharmaceuticals Logo
 
Press spacebar to pause and continue. Press esc to stop.